FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Wants Medical Device Patient Preference Feedback

FDA solicits feedback on its priority list of patient preference-sensitive areas intended to help the medical device industry and researchers.

Medical Devices

FDA OKs Medtronic CareLink SmartSync Device Manager

FDA approves Medtronics CareLink SmartSync device manager that works through an Apple iPad.

Corporate Compliance Guidance Tracks GMP: Attorney

Attorney Anne Walsh says a Justice Department guidance document on evaluating corporate compliance programs is similar to GMP requirements on drug and...

Medical Devices

New FDA Actions on Breast Implants

FDA says it wont ban textured breast implants but is taking steps to improve risk communication with women and healthcare providers and to improve fut...

Medical Devices

ADA Asks FDA Action Against SmileDirectClub

The American Dental Association asks FDA to take legal action against SmileDirectClub for essentially selling prescription teeth aligners and dental i...

FDA General

Sharpless Vows to Listen to FDA Experts

Delivering the annual FDLI keynote address, FDA acting commissioner Ned Sharpless vows to heed the advice of previous commissioners he consulted: to l...

Human Drugs

Agios Pharma sNDA for Tibsovo Approved

FDA approves an Agios Pharmaceuticals supplemental NDA to update the U.S. prescribing information for Tibsovo to include adult patients with newly dia...

Federal Register

International Cosmetics Regulation Meeting

Federal Register notice: FDA announces a 6/5 public meeting entitled International Cooperation on Cosmetics Regulation (ICCR) Preparation for ICCR-13...

Biologics

Sanofi Pasteur Gains Approval for Dengvaxia

FDA approves a Sanofi Pasteur BLA for Dengvaxia, the first vaccine approved for preventing dengue disease caused by all dengue virus serotypes.

Human Drugs

Continue OTC Monograph Reform: Health Groups

Eight public health advocacy organizations urge FDA to continue to work for passage of legislation to reform the OTC drug monograph system.